This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia
International Journal of Clinical Oncology Open Access 10 May 2022
-
Exploring the tissue tropism of pseudorabies virus based on miRNA level analysis
BMC Microbiology Open Access 11 June 2019
-
An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjects
BMC Research Notes Open Access 08 May 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fluckiger AC, Rossi JF, Bussel A, Bryon P, Banchereau J, Defrance T . Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood 1992; 80: 3173–3181.
Kurtova AV, Balakrishnan K, Chen R, Ding W, Schnabl S, Quiroga MP et al. Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood 2009; 114: 4441–4450.
Willimott S, Baou M, Naresh K, Wagner SD . CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia. Br J Haematol 2007; 138: 721–732.
Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793–1801.
Klein U, Lia M, Crespo M, Siegel R, Shen Q, Mo T et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 2010; 17: 28–40.
Frenquelli M, Muzio M, Scielzo C, Fazi C, Scarfo L, Rossi C et al. MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27. Blood 2010; 115: 3949–3959.
Wang M, Tan LP, Dijkstra MK, van Lom K, Robertus JL, Harms G et al. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterised by low miR-150 and high BIC/miR-155 expression. J Pathol 2008; 215: 13–20.
Unno K, Zhou Y, Zimmerman T, Platanias LC, Wickrema A . Identification of a novel microRNA cluster miR-193b-365 in multiple myeloma. Leuk Lymphoma 2009; 50: 1865–1871.
Lowery AJ, Miller N, Dwyer RM, Kerin MJ . Dysregulated miR-183 inhibits migration in breast cancer cells. BMC Cancer 2010; 10: 502.
Elcheva I, Goswami S, Noubissi FK, Spiegelman VS . CRD-BP protects the coding region of betaTrCP1 mRNA from miR-183-mediated degradation. Mol Cell 2009; 35: 240–246.
Ucar A, Vafaizadeh V, Jarry H, Fiedler J, Klemmt PA, Thum T et al. miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. Nat Genet 2010; 42: 1101–1108.
Mu P, Han YC, Betel D, Yao E, Squatrito M, Ogrodowski P et al. Genetic dissection of the miR-17–92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 2009; 23: 2806–2811.
Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008; 132: 875–886.
Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010; 12: 247–256.
O’Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT . c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435: 839–843.
Scielzo C, Apollonio B, Scarfo L, Janus A, Muzio M, Ten Hacken E et al. The functional in vitro response to CD40 ligation reflects a different clinical outcome in patients with chronic lymphocytic leukemia. Leukemia 2011; e-pub ahead of print 28 June 2011; doi: 10.1038/leu.2011.149.
Bousquet M, Harris MH, Zhou B, Lodish HF . MicroRNA miR-125b causes leukemia. Proc Natl Acad Sci USA 2010; 107: 21558–21563.
Malumbres R, Sarosiek KA, Cubedo E, Ruiz JW, Jiang X, Gascoyne RD et al. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 2009; 113: 3754–3764.
Acknowledgements
This work was supported by a grant from the Kay Kendall Leukaemia Fund to SDW.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Rights and permissions
About this article
Cite this article
Willimott, S., Wagner, S. Stromal cells and CD40 ligand (CD154) alter the miRNome and induce miRNA clusters including, miR-125b/miR-99a/let-7c and miR-17-92 in chronic lymphocytic leukaemia. Leukemia 26, 1113–1116 (2012). https://doi.org/10.1038/leu.2011.299
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2011.299
This article is cited by
-
Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia
International Journal of Clinical Oncology (2022)
-
Exploring the tissue tropism of pseudorabies virus based on miRNA level analysis
BMC Microbiology (2019)
-
An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjects
BMC Research Notes (2018)
-
Reciprocal regulation of MicroRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells
Molecular Cancer (2014)
-
The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease
Cell Death & Differentiation (2013)